Format

Send to

Choose Destination
See comment in PubMed Commons below
Chin J Cancer. 2013 Aug;32(8):419-26. doi: 10.5732/cjc.013.10038. Epub 2013 May 14.

Clinical implications of microRNAs in liver cancer stem cells.

Author information

1
Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China. stefma@hku.hk.

Abstract

The prognosis of patients diagnosed with hepatocellular carcinoma (HCC) is often dismal, mainly due to late presentation, high recurrence rate, and frequent resistance to chemotherapy and radiotherapy. Accumulating evidence on the differential microRNA (miRNA) expression patterns between non-tumor and HCC tissues or between liver cancer stem cells (CSCs) and non-CSC subsets and the significant clinical implications of these differences suggest that miRNAs are a promising, non-invasive marker for the prognosis and diagnosis of the disease. This perspective article summarizes the current knowledge of miRNAs in liver CSCs and highlights the need for further investigations of the role of miRNAs in regulating liver CSC subsets for possible future clinical applications.

PMID:
23668930
PMCID:
PMC3845583
DOI:
10.5732/cjc.013.10038
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cancer Center,Sun Yat-sen University Icon for PubMed Central
    Loading ...
    Support Center